latest news releases from the newsroom
National CineMedia, Inc.
National CineMedia, Inc. Announces Second Quarter 2007 Earnings Release Date and Conference Call
CENTENNIAL, Colo., July 26, 2007 (PRIME NEWSWIRE) -- National CineMedia, Inc. (Nasdaq:NCMI), the managing member and owner of 44.8% of National CineMedia, LLC, the operator of the largest digital in-theatre network in North America, today announced that the company will release its fiscal second quarter results after the market close on Thursday, August 9, 2007, to be followed by a conference call at 5:00 p.m. eastern time.
Kellogg Announces Strong First Half and Increased Investment
BATTLE CREEK, Mich., July 26, 2007 (PRIME NEWSWIRE) -- Kellogg Company (NYSE:K) today reported excellent second quarter sales, operating profit, earnings, and cash flow growth. The Company posted better-than-expected results despite continued inflation and a difficult competitive environment. Effective innovation and brand building both contributed to the quarter's growth and provide additional confidence for the remainder of the year.
Alphatec Holdings, Inc.
Alphatec Holdings, Inc. to Present At Upcoming Conference
CARLSBAD, Calif., July 26, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will attend the 27th Annual Canaccord Adams Global Growth Conference in Boston, MA. Dirk Kuyper, President and Chief Executive Officer of Alphatec, is scheduled to present at 4:00 p.m. EDT on Wednesday, August 8, 2007, at the InterContinental Hotel in Boston, MA.
American Mold Guard Inc.
AMG Scientific to Begin Infection Control Study At Rush University Medical Center, Chicago
SAN JUAN CAPISTRANO, Calif., July 26, 2007 (PRIME NEWSWIRE) -- American Mold Guard, Inc. (Nasdaq:AMGI), an industry leader in the field of antimicrobial surface treatment services, announced today through its wholly owned subsidiary, AMG Scientific, LLC, that it is funding a study at Rush University Medical Center in Chicago aimed at controlling hospital-acquired infections.